Traumatic Brain InjuryCognitive functionHealthy volunteersDevice
What this study is
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
What's being tested
- Transcranial Direct Current Stimulation
Intervention · DEVICE
In tDCS, electrodes are applied on the scalp to transmit direct current at low current amplitudes.
Study details
- Sponsor
- Massachusetts General Hospital
- Conditions
- Traumatic Brain Injury · Major Depressive Disorder · Bipolar Disorder · Schizophrenia · Attention Deficit Hyperactivity Disorder · Borderline Personality Disorder · Substance Use Disorders
- Enrolling
- 600 people
- Starts
- 2014-09
- Est. completion
- 2026-04
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 65 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Male and female outpatients 18-65 years of age
- A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
You can't join if
- Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy.
- Active substance dependence (except for tobacco and cannabis).
- Pregnant or nursing females.
- Inability to participate in testing procedures.
- Diagnosis of psychiatric of neurological disorder
- Ongoing treatment with any psychotropic medications.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMassachusetts General Hospital
Boston, Massachusetts, United States
- Blake Andreou, BS · Contact6177248780bandreou@mgh.harvard.edu
Recruiting
Study team
Sponsor
Massachusetts General Hospital
Study ID 2014P001428
Principal investigator
Joan Camprodon, MD, PhD, MPH
Massachusetts General Hospital
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.